Risk averse US needs to address device processes
This article was originally published in SRA
A reminder that it's not just the EU device regulatory system that is under intense scrutiny came on 13 April when the US Senate's Special Committee on Aging held a hearing on the device approval process and the need to ensure safety.
You may also be interested in...
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.
EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.